Company Filing History:
4 out of 815 
3 out of 9 
3 out of 134 
Years Active: 2017-2022
Title: Abhay Rathore: Innovator in Medical Therapeutics
Introduction
Abhay Rathore, an accomplished inventor based in Singapore, has made significant contributions to the field of medical therapeutics. With a portfolio of four patents, his work primarily focuses on innovative treatments for viral infections and related medical conditions.
Latest Patents
One of Rathore's notable inventions is the use of serotonergic drugs to treat virus-induced thrombocytopenia. This invention outlines methods for treating thrombocytopenia by blocking serotonin activity, particularly targeting conditions induced by dengue or Japanese Encephalitis virus. The invention identifies specific inhibitors, such as ketanserin, WAY-100135, sarpogrelate, and fluoxetine, which can be utilized in treatment protocols.
Another critical patent pertains to dosing regimens of celgosivir to treat dengue infections. This invention presents methods for administering a compound of Formula (I) within the onset of fever due to dengue and continuing treatments as required. The methods aim to enhance the recovery from primary and secondary DENV1-4 viral infections, showcasing Rathore’s commitment to addressing urgent health challenges.
Career Highlights
Abhay Rathore has been associated with prominent institutions like the National University of Singapore and 60 Degrees Pharmaceuticals, LLC. His professional background includes substantial research experience and a focus on advancing therapeutic options for complex medical issues.
Collaborations
Throughout his career, Rathore has collaborated with esteemed professionals in the field, including Geoffrey Stuart Dow and Subhash G Vasudevan. These partnerships have fostered a dynamic exchange of knowledge and innovation, further enhancing the impact of his work.
Conclusion
Abhay Rathore’s innovative spirit and dedication to medical research have positioned him as a leading figure in the development of new therapeutic solutions. His patents not only reflect his ingenuity but also illustrate the potential advancements in treating viral infections that could significantly impact patient care globally.